212 related articles for article (PubMed ID: 26845760)
1. A New Approach for Deep Gray Matter Analysis Using Partial-Volume Estimation.
Bonnier G; Kober T; Schluep M; Du Pasquier R; Krueger G; Meuli R; Granziera C; Roche A
PLoS One; 2016; 11(2):e0148631. PubMed ID: 26845760
[TBL] [Abstract][Full Text] [Related]
2. Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).
Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
Eur Radiol; 2021 Feb; 31(2):706-715. PubMed ID: 32851443
[TBL] [Abstract][Full Text] [Related]
3. Determinants of Deep Gray Matter Atrophy in Multiple Sclerosis: A Multimodal MRI Study.
Pontillo G; Cocozza S; Lanzillo R; Russo C; Stasi MD; Paolella C; Vola EA; Criscuolo C; Borrelli P; Palma G; Tedeschi E; Morra VB; Elefante A; Brunetti A
AJNR Am J Neuroradiol; 2019 Jan; 40(1):99-106. PubMed ID: 30573464
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Intracortical Lesions on Volumes of Subcortical Structures in Multiple Sclerosis.
Kalinin I; Makshakov G; Evdoshenko E
AJNR Am J Neuroradiol; 2020 May; 41(5):804-808. PubMed ID: 32381540
[TBL] [Abstract][Full Text] [Related]
5. Deep gray matter and fatigue in MS: a T1 relaxation time study.
Niepel G; Tench ChR; Morgan PS; Evangelou N; Auer DP; Constantinescu CS
J Neurol; 2006 Jul; 253(7):896-902. PubMed ID: 16525881
[TBL] [Abstract][Full Text] [Related]
6. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.
Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
Clin Neuroradiol; 2019 Mar; 29(1):51-64. PubMed ID: 29299614
[TBL] [Abstract][Full Text] [Related]
7. Low-frequency MR elastography reveals altered deep gray matter viscoelasticity in multiple sclerosis.
Kiss C; Wurth S; Heschl B; Khalil M; Gattringer T; Enzinger C; Ropele S
Neuroimage Clin; 2024; 42():103606. PubMed ID: 38669859
[TBL] [Abstract][Full Text] [Related]
8. MP2RAGE provides new clinically-compatible correlates of mild cognitive deficits in relapsing-remitting multiple sclerosis.
Simioni S; Amarù F; Bonnier G; Kober T; Rotzinger D; Du Pasquier R; Schluep M; Meuli R; Sbarbati A; Thiran JP; Krueger G; Granziera C
J Neurol; 2014 Aug; 261(8):1606-13. PubMed ID: 24912471
[TBL] [Abstract][Full Text] [Related]
9. Subcortical deep gray matter pathology in patients with multiple sclerosis is associated with white matter lesion burden and atrophy but not with cortical atrophy: a diffusion tensor MRI study.
Cappellani R; Bergsland N; Weinstock-Guttman B; Kennedy C; Carl E; Ramasamy DP; Hagemeier J; Dwyer MG; Patti F; Zivadinov R
AJNR Am J Neuroradiol; 2014 May; 35(5):912-9. PubMed ID: 24335548
[TBL] [Abstract][Full Text] [Related]
10. Multiparameter MRI quantification of microstructural tissue alterations in multiple sclerosis.
Lommers E; Simon J; Reuter G; Delrue G; Dive D; Degueldre C; Balteau E; Phillips C; Maquet P
Neuroimage Clin; 2019; 23():101879. PubMed ID: 31176293
[TBL] [Abstract][Full Text] [Related]
11. Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis.
Steenwijk MD; Daams M; Pouwels PJ; J Balk L; Tewarie PK; Geurts JJ; Barkhof F; Vrenken H
Hum Brain Mapp; 2015 May; 36(5):1796-807. PubMed ID: 25627545
[TBL] [Abstract][Full Text] [Related]
12. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
Sacco R; Bisecco A; Corbo D; Della Corte M; d'Ambrosio A; Docimo R; Gallo A; Esposito F; Esposito S; Cirillo M; Lavorgna L; Tedeschi G; Bonavita S
J Neurol; 2015 Jul; 262(7):1691-7. PubMed ID: 25957638
[TBL] [Abstract][Full Text] [Related]
13. Corpus callosum atrophy correlates with gray matter atrophy in patients with multiple sclerosis.
Klawiter EC; Ceccarelli A; Arora A; Jackson J; Bakshi S; Kim G; Miller J; Tauhid S; von Gizycki C; Bakshi R; Neema M
J Neuroimaging; 2015; 25(1):62-7. PubMed ID: 24816394
[TBL] [Abstract][Full Text] [Related]
14. Thalamic lesions in multiple sclerosis by 7T MRI: Clinical implications and relationship to cortical pathology.
Harrison DM; Oh J; Roy S; Wood ET; Whetstone A; Seigo MA; Jones CK; Pham D; van Zijl P; Reich DS; Calabresi PA
Mult Scler; 2015 Aug; 21(9):1139-50. PubMed ID: 25583851
[TBL] [Abstract][Full Text] [Related]
15. Characterization of gray-matter multiple sclerosis lesions using double inversion recovery, diffusion, contrast-enhanced, and volumetric MRI.
Parra Corral MA; Govindarajan ST; Stefancin P; Bangiyev L; Coyle PK; Duong TQ
Mult Scler Relat Disord; 2019 Jun; 31():74-81. PubMed ID: 30951968
[TBL] [Abstract][Full Text] [Related]
16. Single scan quantitative gradient recalled echo MRI for evaluation of tissue damage in lesions and normal appearing gray and white matter in multiple sclerosis.
Xiang B; Wen J; Cross AH; Yablonskiy DA
J Magn Reson Imaging; 2019 Feb; 49(2):487-498. PubMed ID: 30155934
[TBL] [Abstract][Full Text] [Related]
17. Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging.
Ge Y; Jensen JH; Lu H; Helpern JA; Miles L; Inglese M; Babb JS; Herbert J; Grossman RI
AJNR Am J Neuroradiol; 2007 Oct; 28(9):1639-44. PubMed ID: 17893225
[TBL] [Abstract][Full Text] [Related]
18. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
[TBL] [Abstract][Full Text] [Related]
19. High-resolution T1-relaxation time mapping displays subtle, clinically relevant, gray matter damage in long-standing multiple sclerosis.
Steenwijk MD; Vrenken H; Jonkman LE; Daams M; Geurts JJ; Barkhof F; Pouwels PJ
Mult Scler; 2016 Sep; 22(10):1279-88. PubMed ID: 26564997
[TBL] [Abstract][Full Text] [Related]
20. Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.
Hojjat SP; Kincal M; Vitorino R; Cantrell CG; Feinstein A; Zhang L; Lee L; O'Connor P; Carroll TJ; Aviv RI
AJNR Am J Neuroradiol; 2016 Aug; 37(8):1454-61. PubMed ID: 27012299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
